Late‐onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer

Immune‐related adverse events (irAEs) occur in rare cases, even after the completion of immune checkpoint inhibitor (ICI) therapy. We encountered a lung cancer patient diagnosed with acute‐onset type 1 diabetes mellitus (DM) 7 months after the cessation of ICI. A 68‐year‐old woman was referred to ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichihara, Seiya, Kunishige, Michihiro, Kadota, Naoki, Okano, Yoshio, Machida, Hisanori, Hatakeyama, Nobuo, Naruse, Keishi, Shinohara, Tsutomu, Takeuchi, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807438/
https://www.ncbi.nlm.nih.gov/pubmed/36411591
http://dx.doi.org/10.1111/1759-7714.14736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807438/
https://www.ncbi.nlm.nih.gov/pubmed/36411591
http://dx.doi.org/10.1111/1759-7714.14736

Ejemplares similares